Atlas Trials

Vabiotech

2 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Vabiotech

RecordFirmDate
Assess the Safety and Immunogenicity of PNEUMOSIL® Vaccine in Healthy Vietnamese Children, 6 Weeks to 24 Months of Age (NCT05140720)Vabiotech2022-01-25
The Transparent Safety Study of the 5 in 1 (DTwP-rHepB-Hib) Combination Vaccine Produced by the Indian Serine Institute in Children of Viet Nam Healthy From 6 to 12 Weeks of Age in a 3-dose Regimen, the Interval Between Doses is 4 Weeks (NCT03931239)Vabiotech2018-03-01

Track Vabiotech automatically

Every clearance here is in the API, with alerts when new ones post.